Unité des Virus Émergents (UVE: Aix-Marseille Univ-IRD 190-Inserm 1207), Marseille, France.
EMBO Rep. 2022 May 4;23(5):e53820. doi: 10.15252/embr.202153820. Epub 2022 Mar 3.
Engineering recombinant viruses is a pre-eminent tool for deciphering the biology of emerging viral pathogens such as the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, the large size of coronavirus genomes renders the current reverse genetics methods challenging. Here, we describe a simple method based on "infectious subgenomic amplicons" (ISA) technology to generate recombinant infectious coronaviruses with no need for reconstruction of the complete genomic cDNA and apply this method to SARS-CoV-2 and also to the feline enteric coronavirus. In both cases we rescue wild-type viruses with biological characteristics similar to original strains. Specific mutations and fluorescent red reporter genes can be readily incorporated into the SARS-CoV-2 genome enabling the generation of a genomic variants and fluorescent reporter strains for in vivo experiments, serological diagnosis, and antiviral assays. The swiftness and simplicity of the ISA method has the potential to facilitate the advance of coronavirus reverse genetics studies, to explore the molecular biological properties of the SARS-CoV-2 variants, and to accelerate the development of effective therapeutic reagents.
工程重组病毒是破译新兴病毒病原体(如严重急性呼吸系统综合症冠状病毒 2 型(SARS-CoV-2))生物学特性的卓越工具。然而,冠状病毒基因组的庞大尺寸使得当前的反向遗传学方法具有挑战性。在这里,我们描述了一种基于“感染性亚基因组扩增子(ISA)”技术的简单方法,该方法无需构建完整的基因组 cDNA 即可生成重组传染性冠状病毒,并将该方法应用于 SARS-CoV-2 和猫传染性肠道冠状病毒。在这两种情况下,我们都拯救了具有与原始菌株相似生物学特性的野生型病毒。特定的突变和荧光红色报告基因可以很容易地整合到 SARS-CoV-2 基因组中,从而可以生成基因组变异株和荧光报告株,用于体内实验、血清学诊断和抗病毒测定。ISA 方法的迅速和简单性有可能促进冠状病毒反向遗传学研究的进展,探索 SARS-CoV-2 变异株的分子生物学特性,并加速有效治疗试剂的开发。